Testing RC1416 injection for COPD flare-ups
Part of Lungs & breathing clinical trials.
This trial tests an injection called RC1416 for people with moderate-to-severe COPD who still have flare-ups despite using triple inhaler therapy. It may help reduce those flare-ups and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 85 years old.
- You have had COPD for at least 12 months.
- You are a current or former smoker (at least 10 pack-years) or have been exposed to other risk factors.
- You have had at least 2 moderate or 1 severe COPD flare-up in the past year.
- You have been on triple inhaler therapy (ICS, LABA, and LAMA) for at least 3 months.
- Your blood eosinophil count is at least 150 per cubic millimeter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine, RC1416, for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It aims to see if the treatment can reduce asthma attacks and improve breathing.
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
This trial tests a new injection called XKH001 to see if it can reduce COPD flare-ups and improve lung function. It may help people with moderate to severe COPD who have had recent flare-ups despite using standard inhaled medicines.
This trial tests a new medicine called CM512 (given as an injection) to see if it can reduce COPD flare-ups and improve lung function. It is for people with moderate-to-severe COPD who have had recent flare-ups despite using inhalers.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
Hear when a new Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.